Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04758780
Status:
RECRUITING
Last Update Posted:
2023-02-21
First Post:
2021-01-14
Brief Title:
Imaging Performance Assessment of 89Zirconium-labelled Girentuximab 89Zr-TLX250 PET-CT in Metastatic Triple Negative Breast Cancer Patients
Sponsor:
Institut Cancerologie de lOuest
Organization:
Institut Cancerologie de lOuest
Organization Data
Organization:
Institut Cancerologie de lOuest
Class:
OTHER
Study ID:
ICO-2020-25
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Institut Cancerologie de lOuest
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| SIRIC ILIAD | UNKNOWN |
| Telix Pharmaceutical | UNKNOWN |